Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 24, 2011, Pages 9875-9880

  Wakao, Shohei ^a   Kitada, Masaaki ^a   Kuroda, Yasumasa ^a   Shigemoto, Taeko ^a   Matsuse, Dai ^a   Akashi, Hideo ^a   Tanimura, Yukihiro ^a   Tsuchiyama, Kenichiro ^a   Kikuchi, Tomohiko ^a   Goda, Makoto ^b   Nakahata, Tatsutoshi ^c   Fujiyoshi, Yoshinori ^b   Dezawa, Mari ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

ES cells; Mesenchymal stem cells; TRA 1 81

Indexed keywords

ENDOGLIN; KRUPPEL LIKE FACTOR 4; OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 3; TRANSCRIPTION FACTOR SOX2; VIRUS VECTOR;

ARTICLE; CELL RENEWAL; EPIGENETICS; FIBROBLAST; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MULTILINEAGE DIFFERENTIATING STRESS ENDURING CELL; ONCOGENE C MYC; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; STOCHASTIC MODEL; STRESS;

ADAPTATION, PHYSIOLOGICAL; ADULT; ANIMALS; ANTIGENS, CD; ANTIGENS, SURFACE; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CELL DIFFERENTIATION; CELL LINE; CELL LINEAGE; CELLS, CULTURED; DERMIS; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; INDUCED PLURIPOTENT STEM CELLS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MICE; MICE, INBRED NOD; MICE, SCID; OCTAMER TRANSCRIPTION FACTOR-3; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOXB1 TRANSCRIPTION FACTORS; STAGE-SPECIFIC EMBRYONIC ANTIGENS; STRESS, PHYSIOLOGICAL; TRANSFECTION;

IPS;

EID: 79959976178     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1100816108     Document Type: Article

References (35)

1. Kørbling M, Estrov Z (2003) Adult stem cells for tissue repair - a new therapeutic concept? N Engl J Med 349:570-582.
2. Thomas ED (2000) Landmarks in the development of hematopoietic cell transplantation. World J Surg 24:815-818.
3. Thomson JA, et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147. (Pubitemid 28516247)
4. Takahashi K, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872. (Pubitemid 350138099)
5. Sullivan GJ, Bai Y, Fletcher J, Wilmut I (2010) Induced pluripotent stem cells: Epigenetic memories and practical implications. Mol Hum Reprod 16:880-885.
6. Yamanaka S (2009) Elite and stochastic models for induced pluripotent stem cell generation. Nature 460:49-52.
7. Huangfu D, et al. (2008) Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26:1269-1275.
8. Kawamura T, et al. (2009) Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 460:1140-1144.
9. Li W, et al. (2009) Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 4:16-19.
10. Lin T, et al. (2009) A chemical platform for improved induction of human iPSCs. Nat Methods 6:805-808.
11. Byrne JA, Nguyen HN, Reijo Pera RA (2009) Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblasts. PLoS ONE 4:e7118.
12. Eminli S, et al. (2009) Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet 41:968-976.
13. Hanna J, et al. (2009) Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462:595-601.
14. Ou L, Wang X, Zou F (2010) Is iPS cell the panacea? IUBMB Life 62:170-175.
15. Abollo-Jiménez F, Jiménez R, Cobaleda C (2010) Physiological cellular reprogramming and cancer. Semin Cancer Biol 20:98-106.
16. Kuroda Y, et al. (2010) Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci USA 107:8639-8643.
17. Nishimura EK, et al. (2002) Dominant role of the niche in melanocyte stem-cell fate determination. Nature 416:854-860. (Pubitemid 34453742)
18. Murga M, Yao L, Tosato G (2004) Derivation of endothelial cells from CD34- umbilical cord blood. Stem Cells 22:385-395. (Pubitemid 38736622)
19. Middleton J, et al. (2005) A comparative study of endothelial cell markers expressed in chronically inflamed human tissues: MECA-79, Duffy antigen receptor for chemokines, von Willebrand factor, CD31, CD34, CD105 and CD146. J Pathol 206:260-268. (Pubitemid 40903190)
20. Crisan M, et al. (2008) A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3:301-313.
21. Nagoshi N, et al. (2008) Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad. Cell Stem Cell 2:392-403. (Pubitemid 351455244)
22. Fernandes KJ, et al. (2004) A dermal niche for multipotent adult skin-derived precursor cells. Nat Cell Biol 6:1082-1093. (Pubitemid 39468009)
23. Biernaskie J, et al. (2009) SKPs derive from hair follicle precursors and exhibit properties of adult dermal stem cells. Cell Stem Cell 5:610-623.
24. Gimble JM, Katz AJ, Bunnell BA (2007) Adipose-derived stem cells for regenerative medicine. Circ Res 100:1249-1260. (Pubitemid 46742916)
25. Hermann A, et al. (2004) Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells. J Cell Sci 117:4411-4422. (Pubitemid 39360068)
26. Pittenger MF, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147. (Pubitemid 29282067)
27. Dezawa M, et al. (2004) Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest 113:1701-1710. (Pubitemid 39071662)
28. Oyagi S, et al. (2006) Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats. J Hepatol 44:742-748.
29. Lowry WE, et al. (2008) Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci USA 105:2883-2888. (Pubitemid 351723638)
30. Subramanyam D, Blelloch R (2009) Watching reprogramming in real time. Nat Biotechnol 27:997-998.
31. Chan EM, et al. (2009) Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat Biotechnol 27:1033-1037.
32. Sommer CA, et al. (2009) Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 27:543-549.
33. Chou YF, et al. (2008) The growth factor environment defines distinct pluripotent ground states in novel blastocyst-derived stem cells. Cell 135:449-461.
34. Zhang X, et al. (2009) A role for NANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A. J Cell Biol 184:67-82.
35. Lee J, Go Y, Kang I, Han YM, Kim J (2010) Oct-4 controls cell-cycle progression of embryonic stem cells. Biochem J 426:171-181.